Splenic marginal zone lymphoma: Comprehensive analysis of gene expression and miRNA profiling

Modern Pathology

Volumn 26, Issue 7, 2013, Pages 889-901

  Arribas, Alberto J ^a   Gómez Abad, Cristina ^b   Sánchez Beato, Margarita ^c   Martinez, Nerea ^d   Dilisio, Lorena ^d   Casado, Felipe ^a   Cruz, Miguel A ^a   Algara, Patrocinio ^a   Piris, Miguel A ^d   Mollejo, Manuela ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

marginal zone lymphoma; miRNA expression profile; therapeutic target

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 145; MICRORNA 155; MICRORNA 193B; MICRORNA 21; MICRORNA 27B; MICRORNA 29A; MICRORNA 29B; MICRORNA 34A; MICRORNA 376A; MICRORNA 377; MICRORNA 424; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER INFILTRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHOID HYPERPLASIA; LYMPHOID TISSUE; MALE; MANTLE CELL LYMPHOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SPLENIC MARGINAL ZONE LYMPHOMA; DNA MICROARRAY; GENETICS; IN SITU HYBRIDIZATION; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN TUMOR;

ADULT; AGED; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; SPLENIC NEOPLASMS; TRANSCRIPTOME;

EID: 84879994377     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.220     Document Type: Article

References (46)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematpoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC): Lyon; 2008; ch 10: Pp 185-187.
2. Mateo M, Mollejo M, Villuendas R, et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999;154:1583-1589. (Pubitemid 29226452)
3. Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 2011;117:1595-1604.
4. Watkins AJ, Hamoudi RA, Zeng N, et al. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma. PLoS One 2012;7: E44997.
5. Ruiz-Ballesteros E, Mollejo M, Mateo M, et al. MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 2007;21:2547-2549. (Pubitemid 350148903)
6. BaróC, Salido M, Espinet B, et al. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leuk Res 2008;32:727-736. (Pubitemid 351330174)
7. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86.
8. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002;99:1299-1304. (Pubitemid 34547084)
9. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, et al. Splenic marginal zone lymphoma: Proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 2005;106: 1831-1838. (Pubitemid 41208601)
10. Rossi D, Trifonov V, Fangazio M, et al. The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development. J Exp Med 2012;209: 1537-1551.
11. Kiel MJ, Velusamy T, Betz BL, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med 2012;209:1553-1565.
12. Basso K, Sumazin P, Morozov P, et al. Identification of the human mature B cell miRNome. Immunity 2009;30:744-752.
13. Jima DD, Zhang J, Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel micro-RNAs. Blood 2010;116:e118-e127.
14. Bouteloup M, Verney A, Rachinel N, et al. MicroRNA expression profile in splenic marginal zone lymphoma. Br J Haematol 2012;156:279-281.
15. Peveling-Oberhag J, Crisman G, Schmidt A, et al. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia 2012;26:1654-1662.
16. Arribas AJ, Campos-Martín Y, Gómez-Abad C, et al. Nodal marginal zone lymphoma: Gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets. Blood 2012;119:e9-e21.
17. Rodríguez A, Villuendas R, Yánéz L, et al. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: Clinical correlation. Leukemia 2007;21:1984-1991. (Pubitemid 47299974)
18. Ach RA, Wang H, Curry B. Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol 2008;8:69.
19. Ritchie ME, Silver J, Oshlack A, et al. A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007;23:2700-2707. (Pubitemid 350048334)
20. Aggarwal M, Sánchez-Beato M, Gómez-López G, et al. Functional signatures identified in B-cell non-Hodgkin lymphoma profiles. Leuk Lymphoma 2009;50: 1699-1708.
21. Di Lisio L, Gómez-López G, Sánchez-Beato M, et al. Mantle cell lymphoma: Transcriptional regulation by microRNAs. Leukemia 2010;24:1335-1342.
22. Troen G, Nygaard V, Jenssen TK, et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. J Mol Diagn 2004;6:297-307. (Pubitemid 39517397)
23. Thieblemont C, Coiffier B. Management of marginal zone lymphomas. Curr Treat Options Oncol 2006;7: 213-222.
24. Shen Y, Iqbal J, Xiao L, et al. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol 2004;5:20.
25. Tan LP, Wang M, Robertus JL, et al. miRNA profiling of B-cell subsets: Specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab Invest 2009;89:708-716.
26. Weill JC, Weller S, Reynaud CA. Human marginal zone B cells. Annu Rev Immunol 2009;27:267-285.
27. Fulci V, Chiaretti S, Goldoni M, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007;109: 4944-4951. (Pubitemid 46827793)
28. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672-675. (Pubitemid 351667616)
29. Van Vlierberghe P, De Weer A, Mestdagh P, et al. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. Br J Haematol 2009;147:686-690.
30. Mi S, Lu J, Sun M, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 2007;104:19971-19976.
31. Asslaber D, Pinö́n JD, Seyfried I, et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 2010;115:4191-4197.
32. Caramuta S, Egyházi S, Rodolfo M, et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010;130:2062-2070.
33. Roehle A, Hoefig KP, Repsilber D, et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 2008;142: 732-744.
34. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-155. Science 2007;316:604-608. (Pubitemid 46683147)
35. Pauley KM, Cha S, Chan EK. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009;32: 189-194.
36. Matsuda A, Suzuki Y, Honda G, et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 2003;22:3307-3318. (Pubitemid 36712943)
37. Kim DM, Chung KS, Choi SJ, et al. RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells. Int J Cancer 2009;125:2520-2527.
38. Kim EJ, Lee SY, Kim TR, et al. TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21(WAF1/Cip1) and PTEN/AKT pathway. Biochem Biophys Res Commun 2010;392:448-453.
39. Tagawa H, Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 2005;19:2013-2016. (Pubitemid 41554018)
40. Pizzimenti S, Ferracin M, Sabbioni S, et al. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic Biol Med 2009;46:282-288.
41. El Desoukey NA, Afify RA, Amin DG, et al. CD200 expression in B-cell chronic lymphoproliferative disorders. J Investig Med 2012;60:56-61.
42. Calin GA, Pekarsky Y, Croce CM. The role of micro-RNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007;20:425-437. (Pubitemid 47260321)
43. Ortega-Paino E, Fransson J, Ek S, et al. Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference. Blood 2008;111:1617-1624. (Pubitemid 351213453)
44. Wilcox A, Hinchliffe KA. Regulation of extranuclear PtdIns5P production by phosphatidylinositol phosphate 4-kinase 2alpha. FEBS Lett 2008;582: 1391-1394.
45. Yoon CH, Miah MA, Kim KP, et al. New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses. EMBO Rep 2010;11:393-399.
46. Salido M, BaróC, Oscier D, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: A multicenter study of the Splenic B-Cell Lymphoma Group. Blood 2010;116:1479-1488.